European Consumers' Tools to Retrieve Health Information Online

Manhattan ResearchSearch engines and Wikipedia play a major role in how European consumers retrieve health information online, reports leading global pharmaceutical and healthcare research firm Manhattan Research from its Cybercitizen® Health Europe v8.0 strategic research and advisory service. With the lack of comprehensive, accredited health portals in many European markets, these tools fill the gap for consumers looking for disease, symptom, treatment, and product information relevant to their language and locality.

The majority of adults online in Europe used search engines to look up health information in the past 12 months, and many report that they turn to a search engine first over going directly to a health site when beginning their quest for information. The collaborative online encyclopedia Wikipedia ranks as a top site used for health in most of the countries surveyed in Cybercitizen® Health Europe.

"Healthcare companies should monitor local Wikipedia sites to ensure that brands and products are represented accurately. The majority of online European consumers expect that pharmaceutical, biotech, and medical device companies monitor Wikipedia entries about their products," said Meredith Abreu Ressi, Vice President of Research at Manhattan Research. "Of course it is important for companies to be vigilant in their approach to editing or altering Wikipedia entries. Making sure that content is complete is one thing - selective removal of content is clearly another."

Cybercitizen® Health Europe is a syndicated multi-client study and advisory service focused on key research topics and trends impacting the European consumer health marketplace - with the goal of enabling companies to make better informed decisions when planning and executing marketing strategies. The study was fielded online among 4,079 European consumers from the United Kingdom, Germany, Spain, Italy, France, Belgium, Sweden, the Netherlands, Poland, and Portugal. For additional product information, please visit www.manhattanresearch.com/ccheu.

Strategic White Paper
The "Connecting with Europeans Online for Health" white paper is derived from Manhattan Research's Cybercitizen® Health Europe v8.0 study and advisory service and contains key market data, trends and strategies for pharmaceutical and healthcare companies. Access the paper here: www.manhattanresearch.com/research/white-papers/
connecting-with-europeans-online-for-health.aspx

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory firm for pharmaceutical and healthcare companies. For more information, visit www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

Most Popular Now

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 vaccine (COMIRNATY® Original/Om...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...

WHO grants prequalification to GSK's Mosquirix - t…

GSK plc (LSE/NYSE: GSK) announced that the World Health Organization (WHO) has awarded prequalification to Mosquirix (also known as RTS,S/AS01), GSK's groundbreaking mala...

Bird's enzyme points toward novel therapies

Thank the rare crested ibis for a clue that could someday help our bodies make better drugs. The species of bird is the only one known to naturally produce an enzyme ...

WHO strongly advises against antibody treatments f…

The antibody drugs sotrovimab and casirivimab-imdevimab are not recommended for patients with COVID-19, says a WHO Guideline Development Group of international experts in...